|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: DYNC1H1 |
Gene summary for DYNC1H1 |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | DYNC1H1 | Gene ID | 1778 |
| Gene name | dynein cytoplasmic 1 heavy chain 1 | |
| Gene Alias | CMT2O | |
| Cytomap | 14q32.31 | |
| Gene Type | protein-coding | GO ID | GO:0000226 | UniProtAcc | Q14204 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 1778 | DYNC1H1 | HTA11_347_2000001011 | Human | Colorectum | AD | 5.57e-17 | 6.56e-01 | -0.1954 |
| 1778 | DYNC1H1 | HTA11_696_2000001011 | Human | Colorectum | AD | 1.42e-03 | 4.49e-01 | -0.1464 |
| 1778 | DYNC1H1 | HTA11_1391_2000001011 | Human | Colorectum | AD | 1.84e-07 | 5.50e-01 | -0.059 |
| 1778 | DYNC1H1 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.71e-08 | 5.65e-01 | 0.096 |
| 1778 | DYNC1H1 | HTA11_10711_2000001011 | Human | Colorectum | AD | 4.71e-04 | 4.87e-01 | 0.0338 |
| 1778 | DYNC1H1 | HTA11_7696_3000711011 | Human | Colorectum | AD | 9.76e-11 | 6.19e-01 | 0.0674 |
| 1778 | DYNC1H1 | HTA11_6818_2000001021 | Human | Colorectum | AD | 4.76e-05 | 4.70e-01 | 0.0588 |
| 1778 | DYNC1H1 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 7.69e-03 | 9.09e-01 | 0.3487 |
| 1778 | DYNC1H1 | A015-C-203 | Human | Colorectum | FAP | 7.13e-22 | 8.29e-02 | -0.1294 |
| 1778 | DYNC1H1 | A002-C-201 | Human | Colorectum | FAP | 2.17e-04 | 6.32e-02 | 0.0324 |
| 1778 | DYNC1H1 | A001-C-119 | Human | Colorectum | FAP | 2.83e-10 | 4.81e-01 | -0.1557 |
| 1778 | DYNC1H1 | A001-C-108 | Human | Colorectum | FAP | 8.07e-09 | 1.94e-01 | -0.0272 |
| 1778 | DYNC1H1 | A002-C-205 | Human | Colorectum | FAP | 1.91e-16 | 3.20e-01 | -0.1236 |
| 1778 | DYNC1H1 | A001-C-104 | Human | Colorectum | FAP | 3.61e-05 | 2.98e-01 | 0.0184 |
| 1778 | DYNC1H1 | A015-C-006 | Human | Colorectum | FAP | 6.99e-12 | 2.80e-01 | -0.0994 |
| 1778 | DYNC1H1 | A015-C-106 | Human | Colorectum | FAP | 1.35e-08 | 1.08e-01 | -0.0511 |
| 1778 | DYNC1H1 | A002-C-114 | Human | Colorectum | FAP | 6.57e-11 | 1.83e-01 | -0.1561 |
| 1778 | DYNC1H1 | A015-C-104 | Human | Colorectum | FAP | 7.60e-24 | 2.72e-01 | -0.1899 |
| 1778 | DYNC1H1 | A001-C-014 | Human | Colorectum | FAP | 5.51e-08 | 1.76e-01 | 0.0135 |
| 1778 | DYNC1H1 | A002-C-016 | Human | Colorectum | FAP | 1.83e-15 | 5.45e-02 | 0.0521 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| Esophagus |  | ESCC: Esophageal squamous cell carcinoma |
| HGIN: High-grade intraepithelial neoplasias | ||
| LGIN: Low-grade intraepithelial neoplasias | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease | ||
| Lung |  | AAH: Atypical adenomatous hyperplasia |
| AIS: Adenocarcinoma in situ | ||
| IAC: Invasive lung adenocarcinoma | ||
| MIA: Minimally invasive adenocarcinoma | ||
| Oral Cavity |  | EOLP: Erosive Oral lichen planus |
| LP: leukoplakia | ||
| NEOLP: Non-erosive oral lichen planus | ||
| OSCC: Oral squamous cell carcinoma | ||
| Prostate |  | BPH: Benign Prostatic Hyperplasia |
| Skin |  | AK: Actinic keratosis |
| cSCC: Cutaneous squamous cell carcinoma | ||
| SCCIS:squamous cell carcinoma in situ | ||
| Thyroid |  | ATC: Anaplastic thyroid cancer |
| HT: Hashimoto's thyroiditis | ||
| PTC: Papillary thyroid cancer |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:0051495 | Colorectum | AD | positive regulation of cytoskeleton organization | 89/3918 | 226/18723 | 1.61e-10 | 1.56e-08 | 89 |
| GO:0051656 | Colorectum | AD | establishment of organelle localization | 131/3918 | 390/18723 | 3.00e-09 | 2.06e-07 | 131 |
| GO:0032388 | Colorectum | AD | positive regulation of intracellular transport | 74/3918 | 202/18723 | 1.83e-07 | 7.80e-06 | 74 |
| GO:0032386 | Colorectum | AD | regulation of intracellular transport | 109/3918 | 337/18723 | 5.33e-07 | 1.95e-05 | 109 |
| GO:0051650 | Colorectum | AD | establishment of vesicle localization | 57/3918 | 161/18723 | 1.47e-05 | 3.15e-04 | 57 |
| GO:0051648 | Colorectum | AD | vesicle localization | 59/3918 | 177/18723 | 7.83e-05 | 1.25e-03 | 59 |
| GO:0007051 | Colorectum | AD | spindle organization | 58/3918 | 184/18723 | 4.71e-04 | 5.20e-03 | 58 |
| GO:1902850 | Colorectum | AD | microtubule cytoskeleton organization involved in mitosis | 48/3918 | 147/18723 | 5.87e-04 | 6.21e-03 | 48 |
| GO:0030705 | Colorectum | AD | cytoskeleton-dependent intracellular transport | 60/3918 | 195/18723 | 7.56e-04 | 7.59e-03 | 60 |
| GO:0007052 | Colorectum | AD | mitotic spindle organization | 40/3918 | 120/18723 | 1.03e-03 | 9.61e-03 | 40 |
| GO:0033962 | Colorectum | AD | P-body assembly | 11/3918 | 21/18723 | 1.43e-03 | 1.22e-02 | 11 |
| GO:0007097 | Colorectum | AD | nuclear migration | 10/3918 | 20/18723 | 3.67e-03 | 2.60e-02 | 10 |
| GO:0120162 | Colorectum | AD | positive regulation of cold-induced thermogenesis | 32/3918 | 97/18723 | 3.74e-03 | 2.63e-02 | 32 |
| GO:0051225 | Colorectum | AD | spindle assembly | 37/3918 | 117/18723 | 4.32e-03 | 2.96e-02 | 37 |
| GO:0045787 | Colorectum | AD | positive regulation of cell cycle | 85/3918 | 313/18723 | 4.76e-03 | 3.22e-02 | 85 |
| GO:0051647 | Colorectum | AD | nucleus localization | 11/3918 | 24/18723 | 5.43e-03 | 3.55e-02 | 11 |
| GO:0072384 | Colorectum | AD | organelle transport along microtubule | 28/3918 | 85/18723 | 6.55e-03 | 4.07e-02 | 28 |
| GO:0106106 | Colorectum | AD | cold-induced thermogenesis | 43/3918 | 144/18723 | 7.05e-03 | 4.31e-02 | 43 |
| GO:0120161 | Colorectum | AD | regulation of cold-induced thermogenesis | 43/3918 | 144/18723 | 7.05e-03 | 4.31e-02 | 43 |
| GO:0070507 | Colorectum | AD | regulation of microtubule cytoskeleton organization | 44/3918 | 148/18723 | 7.05e-03 | 4.31e-02 | 44 |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| hsa05132 | Colorectum | AD | Salmonella infection | 102/2092 | 249/8465 | 7.65e-09 | 1.28e-07 | 8.17e-08 | 102 |
| hsa04962 | Colorectum | AD | Vasopressin-regulated water reabsorption | 19/2092 | 44/8465 | 5.48e-03 | 2.48e-02 | 1.58e-02 | 19 |
| hsa051321 | Colorectum | AD | Salmonella infection | 102/2092 | 249/8465 | 7.65e-09 | 1.28e-07 | 8.17e-08 | 102 |
| hsa049621 | Colorectum | AD | Vasopressin-regulated water reabsorption | 19/2092 | 44/8465 | 5.48e-03 | 2.48e-02 | 1.58e-02 | 19 |
| hsa051326 | Colorectum | MSI-H | Salmonella infection | 43/797 | 249/8465 | 5.91e-05 | 8.33e-04 | 6.98e-04 | 43 |
| hsa04145 | Colorectum | MSI-H | Phagosome | 27/797 | 152/8465 | 8.74e-04 | 1.01e-02 | 8.48e-03 | 27 |
| hsa051327 | Colorectum | MSI-H | Salmonella infection | 43/797 | 249/8465 | 5.91e-05 | 8.33e-04 | 6.98e-04 | 43 |
| hsa041451 | Colorectum | MSI-H | Phagosome | 27/797 | 152/8465 | 8.74e-04 | 1.01e-02 | 8.48e-03 | 27 |
| hsa051328 | Colorectum | FAP | Salmonella infection | 67/1404 | 249/8465 | 2.04e-05 | 2.52e-04 | 1.53e-04 | 67 |
| hsa051329 | Colorectum | FAP | Salmonella infection | 67/1404 | 249/8465 | 2.04e-05 | 2.52e-04 | 1.53e-04 | 67 |
| hsa0513210 | Colorectum | CRC | Salmonella infection | 48/1091 | 249/8465 | 2.43e-03 | 1.69e-02 | 1.15e-02 | 48 |
| hsa0513211 | Colorectum | CRC | Salmonella infection | 48/1091 | 249/8465 | 2.43e-03 | 1.69e-02 | 1.15e-02 | 48 |
| hsa05132211 | Esophagus | ESCC | Salmonella infection | 191/4205 | 249/8465 | 6.51e-19 | 5.45e-17 | 2.79e-17 | 191 |
| hsa0414530 | Esophagus | ESCC | Phagosome | 100/4205 | 152/8465 | 3.81e-05 | 1.72e-04 | 8.82e-05 | 100 |
| hsa0496223 | Esophagus | ESCC | Vasopressin-regulated water reabsorption | 33/4205 | 44/8465 | 5.27e-04 | 1.78e-03 | 9.13e-04 | 33 |
| hsa05132310 | Esophagus | ESCC | Salmonella infection | 191/4205 | 249/8465 | 6.51e-19 | 5.45e-17 | 2.79e-17 | 191 |
| hsa04145114 | Esophagus | ESCC | Phagosome | 100/4205 | 152/8465 | 3.81e-05 | 1.72e-04 | 8.82e-05 | 100 |
| hsa0496233 | Esophagus | ESCC | Vasopressin-regulated water reabsorption | 33/4205 | 44/8465 | 5.27e-04 | 1.78e-03 | 9.13e-04 | 33 |
| hsa0513222 | Liver | Cirrhotic | Salmonella infection | 121/2530 | 249/8465 | 2.47e-10 | 5.13e-09 | 3.16e-09 | 121 |
| hsa0414514 | Liver | Cirrhotic | Phagosome | 73/2530 | 152/8465 | 1.61e-06 | 1.78e-05 | 1.10e-05 | 73 |
| Page: 1 2 3 4 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| DYNC1H1 | deletion | Frame_Shift_Del | c.477delN | p.Phe161LeufsTer52 | p.F161Lfs*52 | Q14204 | protein_coding | TCGA-A5-A0GW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
| DYNC1H1 | insertion | In_Frame_Ins | novel | c.7851_7852insGTGGGTCTCAACTTCTCCAGTGCTACTACTCCAGAGCTGTTTTACCTGTGTGAGAGGGGCTTTCTTCCAGGGTCT | p.Leu2630_Leu2631insPheTyrLeuCysGluArgGlyPheLeuProGlySerValGlyLeuAsnPheSerSerAlaThrThrProGluLeu | p.L2630_L2631insFYLCERGFLPGSVGLNFSSATTPEL | Q14204 | protein_coding | TCGA-A5-A0R9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
| DYNC1H1 | deletion | Frame_Shift_Del | c.477delN | p.Phe161LeufsTer52 | p.F161Lfs*52 | Q14204 | protein_coding | TCGA-A5-A7WJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
| DYNC1H1 | deletion | Frame_Shift_Del | novel | c.288_289delNN | p.Glu97IlefsTer5 | p.E97Ifs*5 | Q14204 | protein_coding | TCGA-AJ-A3BH-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD | ||
| DYNC1H1 | deletion | Frame_Shift_Del | c.477delN | p.Phe161LeufsTer52 | p.F161Lfs*52 | Q14204 | protein_coding | TCGA-AP-A0LT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |||
| DYNC1H1 | insertion | In_Frame_Ins | novel | c.4268_4269insACTTATTTTGAAACCTTTTTTTTTTTTTTT | p.Asn1423delinsLysLeuIleLeuLysProPhePhePhePhePhe | p.N1423delinsKLILKPFFFFF | Q14204 | protein_coding | TCGA-B5-A0JR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
| DYNC1H1 | insertion | Frame_Shift_Ins | novel | c.11241dupA | p.Ser3748IlefsTer16 | p.S3748Ifs*16 | Q14204 | protein_coding | TCGA-B5-A11G-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
| DYNC1H1 | insertion | Nonsense_Mutation | novel | c.4374_4375insGAAAAGCTTCCCTGCCCGGTTGCGACAGTATGCGTCCTATGAG | p.Leu1459GlufsTer14 | p.L1459Efs*14 | Q14204 | protein_coding | TCGA-BG-A0LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
| DYNC1H1 | insertion | Frame_Shift_Ins | novel | c.476_477insT | p.Lys162Ter | p.K162* | Q14204 | protein_coding | TCGA-BS-A0UJ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
| DYNC1H1 | insertion | In_Frame_Ins | novel | c.4742_4743insGCGCAG | p.Lys1581_Val1582insArgArg | p.K1581_V1582insRR | Q14204 | protein_coding | TCGA-D1-A102-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |